BiotechTube

Lysozyme hydrochloride + Placebo

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

COPD

Conditions

COPD

Trial Timeline

Aug 1, 2012 โ†’ Mar 1, 2015

NCT ID
NCT01645800

About Lysozyme hydrochloride + Placebo

Lysozyme hydrochloride + Placebo is a approved stage product being developed by Eisai for COPD. The current trial status is completed. This product is registered under clinical trial identifier NCT01645800. Target conditions include COPD.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01645800ApprovedCompleted

Competing Products

20 competing products in COPD

See all competitors
ProductCompanyStageHype Score
Sitafloxacin + Moxifloxacin HydrochlorideDaiichi SankyoApproved
85
Reldesemtiv + PlaceboAstellas PharmaPhase 2
52
Arformoterol (Brovana) + PlaceboSumitomo PharmaApproved
85
Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Salmeterol MDI + PlaceboSumitomo PharmaPhase 3
77
Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Placebo + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + Arformoterol tartrate inhalation solution + PlaceboSumitomo PharmaPhase 2
52
Arformoterol tartrate inhalation solution + TiotropiumSumitomo PharmaApproved
85
Racemic formoterol + Arformoterol tartrate inhalation solution + Racemic formoterolSumitomo PharmaPhase 2
52
Levalbuterol HCl + Levalbuterol HCl + Albuterol Sulfate + PlaceboSumitomo PharmaPhase 3
77
Formoterol Turbuhaler + Budesonide/Formoterol Turbuhaler + Formoterol TurbuhalerAstraZenecaPhase 1
33
AZD2115 + Placebo + Indacaterol + Indacaterol + TiotropiumAstraZenecaPhase 2
52
RoflumilastAstraZenecaPhase 2/3
65
Aclidinium bromide + PlaceboAstraZenecaPhase 3
77
RoflumilastAstraZenecaPre-clinical
23
Symbicort (budesonide/formoterol turbuhaler 320/9ug) + Spiriva (tiotropium bromide 18ug)AstraZenecaApproved
85
AZD7624 + Placebo to matchAstraZenecaPhase 1
33
Roflumilast + PlaceboAstraZenecaPhase 3
77
Aclidinium bromide 100 ฮผg bid + Aclidinium bromide 200 ฮผg bid + Aclidininum bromide 400 ฮผg bid + Placebo + Formoterol 12 ฮผg bidAstraZenecaPhase 2
52
ACL/FOR + PlaceboAstraZenecaApproved
85
TozorakimabAstraZenecaPhase 2
52
AZD1981 + PlaceboAstraZenecaPhase 2
52

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85